The global Pigmentation Disorders Treatment Market is estimated to be valued at US$ 6.84 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pigmentation disorders refer to conditions that result in changes in the production of melanin, which is the pigment that gives skin, hair, and eyes their color. Common pigmentation disorders include melisma, age spots, vitiligo, and albinism. Treatment options include prescription creams, peels, lasers, and in some cases oral medication. These products help improve the appearance of darkened or lightened skin associated with various disorders.
Market key trends:
The increasing use of artificial intelligence in dermatology is one of the major pigmentation disorders treatment market trends. AI is being utilized for tasks like segmentation of lesions, diagnosis of melanomas and other skin conditions, and tracking treatment progress over time. AI tools can analyze large volumes of patient imaging data to identify patterns that may help improve early detection and guide treatment decisions. This reduces reliance on subjective human evaluation alone and may lead to better health outcomes.
Segment Analysis
Content: The global pigmentation disorders treatment market is segmented based on treatment, route of administration, and distribution channel. Based on treatment, the market is classified into topical drugs, laser therapy, chemical peels, microdermabrasion, and others. The topical drugs segment dominated the market in 2022 owing to the presence of effective topical drugs that help reduce hyperpigmentation and treat pigmentation disorders effectively.
Key Takeaways
Market size: The Global Pigmentation Disorders Treatment Market Size is expected to witness high growth, exhibiting CAGR of 6.9% over the forecast period 2023 to 2030, due to increasing awareness about non-invasive and effective treatment options for pigmentation disorders.
Regional analysis: North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to availability of advanced products and devices, high healthcare expenditure and rising awareness about cosmetic procedures in the region. Asia Pacific is expected to witness the fastest growth rate during the forecast period owing to large patient pool, rising disposable income and growth of medical tourism industry.
Key players: Key players operating in the pigmentation disorders treatment market include Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc., among others. Abbvie Inc. (Allergan Inc.) and L'ORÉAL SA (SkinCeuticals International) collectively hold a significant share of the global market owing to their diverse product portfolios for treatment of hyperpigmentation and other pigmentation disorders.
For More Insights, Read: https://www.newsstatix.com/pigmentation-disorders-treatment-market-size-share-and-growth-forecast-2023-2030/
Comments
0 comment